Results 131 to 140 of about 89,285 (227)

Efficacy and Safety of Anti‐IL‐4Rα Stapokibart in Elderly Patients With Moderate‐To‐Severe Atopic Dermatitis

International Journal of Dermatology, EarlyView.
ABSTRACT Background Elderly patients with moderate‐to‐severe atopic dermatitis (AD) often exhibit more heterogeneous inflammatory profiles compared with younger adults. To evaluate the efficacy and safety of stapokibart, an anti‐interleukin‐4 receptor α subunit (IL‐4Rα) monoclonal antibody, in different age subgroups.
Yan Zhao, Litao Zhang, Liming Wu, Bin Yang, Jinyan Wang, Yumei Li, Qingchun Diao, Jingyi Li, Qing Sun, Xiaohong Zhu, Xiaoyong Man, Lihua Wang, Yanyan Feng, Tao Cai, Huiming Zeng, Linfeng Li, Jianyun Lu, Hong Ren, Fuqiu Li, Qianjin Lu, Xiaohua Tao, Rong Xiao, Chao Ji, Jing Sun, Yanping Qiu, Bo Chen, Jianzhong Zhang   +26 more
wiley   +1 more source

Medication Use Patterns, Polypharmacy, and Potentially Inappropriate Medications among Institutionalized Older Adults in East Coast Malaysia: A Cross-sectional Study. [PDF]

J Res Pharm Pract
Ismail A, Mustafa BE, Mohd FN, Musa MFC, Mustafa NS, Mokhtar KI, Ardini YD, Abdul Qader OAJ.   +7 more
europepmc   +1 more source

Inequities in inflammatory bowel disease care: a Tasmanian case study with proposed solutions

Internal Medicine Journal, EarlyView.
Abstract There is well‐recognised inequity of care for people treated with inflammatory bowel disease (IBD) between metropolitan and regional areas. We aim to describe these barriers to care using Tasmania as a case example and to suggest solutions for addressing these barriers that can be used in Tasmania and beyond.
Alexander T Elford, Alyssa Pettersen, Emily Woods, Linda Boxhall, Zachiary Cooke, Anna Prebble, Jennifer Shoobridge, Jarrad Wilson, Scott Fanning   +8 more
wiley   +1 more source

Characterizing Medicare Medication Therapy Management program enrollees with central nervous system-active polypharmacy. [PDF]

J Manag Care Spec Pharm
Hung A, Wilson LE, Smith VA, Erickson R, Tharpe K, Brandt N, Anderson TS, Valdez O, Castora-Binkley M, Pavon J, Hastings SN, Maciejewski ML, Sloan CE.   +12 more
europepmc   +1 more source

Perspectives of Healthcare Professionals, Patients and Family Members on Managing Regular Medications Across the Perioperative Pathway: An Exploratory Qualitative Study

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To explore healthcare professionals', patients', and family members' experiences of managing regular medications across the perioperative pathway in a specialist cancer hospital in Melbourne. Design An exploratory qualitative study using a descriptive‐interpretive approach.
Atefeh Mehrabifar, Elizabeth Manias, Thomas E. Poulton, Bernhard Riedel, Janelle Penno, Patricia Nicholson   +5 more
wiley   +1 more source

Polypharmacy and Dose Adjustment in Chronic Kidney Disease: A Cross-Sectional Study. [PDF]

J Clin Med Res
Mokros J, Matyukhin I, Ritter O, Patschan D.   +3 more
europepmc   +1 more source

Patient Activation Among Individuals with Chronic Illness: A Cross-Sectional Study from Jordan. [PDF]

Healthcare (Basel)
Nusair MB, Khasawneh R, Baali FH, Alkhalil AB, Aldehoun SA, Al-Azzam S.   +5 more
europepmc   +1 more source

Why is the skeleton still in the hospital closet? A look at the complex aetiology of protein-energy malnutrition and its implications for the nutrition care team [PDF]

, 2018
Marshall, S.
core   +1 more source

A Realist Evaluation of a Rapid Response System for Mental State Deterioration in Acute Hospital Settings

Journal of Advanced Nursing, EarlyView.
ABSTRACT Background Patient mental state deterioration presents significant challenges in acute hospital settings, affecting outcomes, increasing reliance on restrictive interventions, and placing additional strain on healthcare staff. Despite its prevalence, consensus on best practice remains limited.
Tendayi Bruce Dziruni, Alison M. Hutchinson, Sandra Keppich‐Arnold, Tracey Bucknall   +3 more
wiley   +1 more source

Prevalence and associated factors for drug-related problems and polypharmacy identified by a pharmacist-led medication review in patients enrolled in a home healthcare program. [PDF]

BMC Geriatr
Salom-Garrigues C, Aragonès E, Giralt M, Campabadal Prats C, Bejarano-Romero F, Martín-Luján F, Romeu M, Canadell L.   +7 more
europepmc   +1 more source